The company
LeMaitre Vascular, Inc.
LMAT · Nasdaq
LMAT stood above a rising 150-day average in 26 of the last 52 weekly readings, and has been out of that trend for the last 11 weeks. It is 12.2% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 11
- Industry in uptrend
- 29% -5 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $60.1M
- Officials’ trades on record
- 1
- Institutions holding
- 303 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 0, Senate 0, executive 1; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 31 Aug 2026filed 8 Oct 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Trent G. KamkeSenior V. P., Operations | sold | 2,928at $107.00 | 8 May 2026filed 11 May 2026 |
| George W. LemaitreChairman and CEO | sold | 27,881at $108.69 | 8 May 2026filed 11 May 2026 |
| Lawrence J. JasinskiDirector | sold | 3,943at $110.00 | 7 May 2026filed 11 May 2026 |
| Bridget A. RossDirector | sold | 5,044at $111.10 | 7 May 2026filed 11 May 2026 |
| George W. LemaitreChairman and CEO | sold | 18,600at $107.64 | 7 May 2026filed 11 May 2026 |
| David B. RobertsPresident and Director | sold | 3,311.68at $107.68 | 11 Mar 2026filed 13 Mar 2026 |
| Trent G. KamkeSenior V. P., Operations | sold | 2,625at $108.50 | 11 Mar 2026filed 13 Mar 2026 |
| George W. LemaitreChairman and CEO | sold | 55,930at $107.81 | 2 Mar 2026filed 2 Mar 2026 |
| David B. RobertsPresident and Director | sold | 8,464at $106.80 | 27 Feb 2026filed 2 Mar 2026 |
| Trent G. KamkeSenior V. P., Operations | sold | 1,044at $110.29 | 27 Feb 2026filed 2 Mar 2026 |
| George W. LemaitreChairman and CEO | sold | 150,000at $106.76 | 26 Feb 2026filed 2 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 3,272,973$314.1M | +128,822+4.1% |
| Conestoga Capital Advisors, LLCreduced · filed 24 Jul 2026 | 1,367,513$131.2M | -109,300−7.4% |
| FIRST TRUST ADVISORS LPadded · filed 11 Aug 2026 | 1,093,502$104.9M | +95,431+9.6% |
| CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 2026 | 963,706$92.5M | +129,177+15.5% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 953,437$91.5M | +41,379+4.5% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 901,416$86.5M | +45,632+5.3% |
| Copeland Capital Management, LLCreduced · filed 4 Aug 2026 | 839,463$80.6M | -31,229−3.6% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 788,835$75.7M | +130,390+19.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 604,833$58.0M | +42,063+7.5% |
| GENEVA CAPITAL MANAGEMENT LLCreduced · filed 6 Aug 2026 | 589,064$56.5M | -164,928−21.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.